KLOW is a multi-peptide research blend commonly described as a combination of GHK-Cu, KPV, BPC-157 and TB-500. Each of these four compounds has its own research history in tissue repair, inflammation and skin biology, and the blend brings them together in a single lyophilized vial. PRIME supplies it as KLOW (Stack) for laboratory research use only; the exact composition and amounts for each batch are listed on the product page and its COA.
What is the KLOW peptide stack?
KLOW is a pre-combined blend rather than a single molecule. The name is generally understood to refer to its components, and it is commonly described as containing the following four peptides:
GHK-Cu
GHK-Cu is a copper complex of the tripeptide glycyl-L-histidyl-L-lysine. GHK occurs naturally in human plasma and binds copper readily. It has been studied in cell and animal models of wound healing and skin remodeling, including research on collagen production and gene expression.
KPV
KPV is the tripeptide lysine-proline-valine, derived from the C-terminal end of alpha-melanocyte-stimulating hormone (alpha-MSH). It has been investigated mainly for anti-inflammatory signaling, including in preclinical models of intestinal inflammation.
BPC-157
BPC-157 is a synthetic 15-amino-acid peptide derived from a protein found in gastric juice. It has been studied extensively in rodent models of tendon, ligament, muscle and gastrointestinal injury, with research also looking at blood vessel formation.
TB-500
TB-500 is a synthetic peptide related to thymosin beta-4, a naturally occurring actin-binding protein. It has been studied for its role in cell migration, blood vessel formation and tissue repair in preclinical models. Descriptions of TB-500 vary as to whether it represents the full thymosin beta-4 sequence or a shorter active fragment.
None of the four components is an FDA-approved medicine. All are research compounds, and the blend itself is a research material. Because it combines several compounds, it suits study designs where all four are of interest rather than work focused on a single mechanism.
How the KLOW components work: mechanisms studied in research
The rationale usually given for this blend is that its components have been studied through different, potentially complementary mechanisms:
- GHK-Cu has been studied for its role in copper delivery to tissues and for effects on genes related to extracellular matrix remodeling and collagen synthesis.
- KPV has been investigated for dampening inflammatory signaling, including effects on the NF-kappa-B pathway in cell models.
- BPC-157 has been explored for effects on angiogenesis, growth factor signaling and nitric oxide pathways in animal injury models.
- TB-500 is associated with actin regulation, which influences how cells move toward and into damaged tissue.
It is important to be clear about the evidence. Most published research examines each of these compounds on its own. Very little research has examined this specific four-part combination, so any expected interaction between the components is a hypothesis rather than an established finding. Researchers who want to attribute an effect to a particular compound will generally also need the individual peptides as controls, along with vehicle-only groups.
Areas of research
- Tissue repair models: soft tissue, tendon and wound healing research, where BPC-157 and TB-500 have the most preclinical data.
- Inflammation: inflammatory signaling in cell and animal models, the main area of KPV research.
- Skin and extracellular matrix: collagen and matrix remodeling, the principal focus of GHK-Cu studies.
- Combination study design: investigating whether multi-mechanism blends behave differently from single compounds.
- Practical workflow: labs using the blend for convenience when all four compounds are part of a study.
KLOW key facts
| Property | Detail |
|---|---|
| Product | KLOW (Stack) |
| Type | Multi-peptide research blend |
| Commonly described components | GHK-Cu, KPV, BPC-157 and TB-500; exact composition and amounts are on the product page and COA |
| Component classes | Copper-binding tripeptide, alpha-MSH-derived tripeptide, gastric protein-derived peptide, thymosin beta-4-related peptide |
| Form supplied | Lyophilized (freeze-dried) powder in a sealed vial |
| Research status | Research material; no component is an FDA-approved medicine |
| Storage | Lyophilized: cold, dry and protected from light. Reconstituted: refrigerated, following lab protocol |
Handling and storage in the lab
Blends follow the same general rules as single peptides, with one added consideration: the most sensitive component sets the limits for the whole vial. Keep unopened KLOW vials refrigerated or frozen, dry and away from light, and let a cold vial reach room temperature before opening.
For laboratory use the blend is commonly reconstituted with a sterile diluent such as bacteriostatic water. Add the diluent slowly down the inside wall of the vial and swirl gently until everything dissolves; do not shake. Because GHK-Cu is a copper complex, which is typically blue, a solution containing it may show a color tint. Label the vial with the product, date and concentration details, refrigerate it, protect it from light and use sterile technique for every access. Avoid repeated freeze-thaw cycles and consider single-use aliquots for longer studies.
These are general laboratory handling notes. Follow your institution's procedures and any documentation supplied with the product.
Quality and lab results
With a blend, documentation matters even more than with a single compound, since you need to know what is in the vial and in what proportion. The exact composition and amounts for KLOW are stated on the product page and on the batch COA. Every PRIME batch has a published certificate of analysis on the lab results page; match the lot number on your vial to its report and keep it with your records.
Related research
To understand the blend, it helps to understand its parts. See BPC-157 vs TB-500 for how the two repair-focused components differ. The GHK-Cu research guide covers the copper peptide in detail, and the KPV research guide looks at the anti-inflammatory tripeptide.
KLOW peptide stack FAQ
What is in the KLOW peptide blend?
KLOW is commonly described as a blend of GHK-Cu, KPV, BPC-157 and TB-500. The exact composition and amounts for each batch are listed on the product page and its COA.
What does KLOW stand for?
The name is generally understood to refer to the blend's components rather than being a compound name in its own right. For research purposes, rely on the listed composition and COA rather than the name.
Has the KLOW combination been studied as a blend?
Very little published research looks at this exact four-part combination. Most studies examine GHK-Cu, KPV, BPC-157 and TB-500 individually, so the rationale for the blend is based on the separate research on each component.
How is KLOW different from a BPC-157 and TB-500 blend?
A two-peptide blend contains only BPC-157 and TB-500. KLOW is commonly described as adding GHK-Cu and KPV, which bring skin and matrix research and anti-inflammatory research into the same vial.
Is KLOW approved for human use?
No. None of its components is an FDA-approved medicine, and PRIME supplies KLOW strictly for laboratory research. It is not intended for human consumption.
For laboratory research use only. Not for human consumption. Not a drug, food or cosmetic.